Live News Categoriesmarket

ETHRIS (ETHRIS) News

Follow ETHRIS (ETHRIS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ETHRIS Asset market Sector Markets 90 days 1 Updated Nov 05, 2026, 08:01 AM UTC Open live news feed

M Ethris Reports Positive Phase 2a Data for ETH47 in Asthma Patients Ethris reported 40-fold lower virus load versus placebo on Day 2, at peak viral replication, in topline Phase 2a data for nasal mRNA candidate ETH47 in asthma patients challenged with rhinovirus. EQUITY | Nov 05, 2026, 08:01 AM UTC